QuidelOrtho director granted 15,532 RSUs

Huennekens R Scott reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Huennekens R Scott reported acquisition or exercise transactions in this Form 4 filing.

QuidelOrtho Corp director R. Scott Huennekens received a grant of restricted stock units as equity compensation. He was awarded 15,532 restricted stock units representing the right to receive an equal number of shares of QuidelOrtho common stock. These restricted stock units will vest on June 25, 2027, and following the grant he holds 15,532 such units directly.

Insider Trade Summary

Grant/Award: 15,532 shares

Grant/Award 1 txn

Insider Huennekens R Scott

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (Equity Grant)	15,532	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (Equity Grant) — 15,532 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
2. F2. The restricted stock units will vest on June 25, 2027.

Key Figures

RSUs granted: 15,532 units RSU exercise price: $0.00 per unit RSUs after transaction: 15,532 units +2 more

5 metrics

RSUs granted 15,532 units Equity grant on June 25, 2026

RSU exercise price $0.00 per unit Restricted stock unit grant terms

RSUs after transaction 15,532 units Total restricted stock units held directly after grant

Vesting date June 25, 2027 Restricted stock units vesting schedule

Underlying common shares 15,532 shares Each RSU represents one share of common stock

Key Terms

Restricted Stock Units, grant/award acquisition, vest, underlying security

4 terms

Restricted Stock Units financial

"He was awarded 15,532 restricted stock units representing the right to receive"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

grant/award acquisition financial

"The transaction is coded as a grant or award acquisition, reflecting compensation"

vest financial

"The restricted stock units will vest on June 25, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

underlying security financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock as the underlying security."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did QuidelOrtho (QDEL) director R. Scott Huennekens report on this Form 4?

He reported receiving a grant of 15,532 restricted stock units as equity compensation. Each unit is tied to one share of QuidelOrtho common stock and vests on June 25, 2027, increasing his direct equity-based holdings.

How many restricted stock units did Huennekens acquire in the QuidelOrtho (QDEL) filing?

He acquired 15,532 restricted stock units in this transaction. These units represent potential future shares of QuidelOrtho common stock and bring his total restricted stock unit holdings reported in this filing to 15,532 units held directly.

When do the newly granted QuidelOrtho (QDEL) restricted stock units vest?

The restricted stock units vest on June 25, 2027. Vesting means that on that date, subject to any applicable conditions, each unit is expected to convert into one share of QuidelOrtho common stock for the reporting person.

What does each QuidelOrtho (QDEL) restricted stock unit represent in this Form 4?

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. The units are a form of equity compensation that typically convert into shares upon vesting, aligning the director’s interests with shareholders over time.

Is the QuidelOrtho (QDEL) Form 4 transaction a market purchase or sale of shares?

No, this Form 4 reports a grant of restricted stock units, not an open-market trade. The transaction is coded as a grant or award acquisition, reflecting compensation rather than a discretionary buy or sell in the public market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 06:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huennekens R Scott

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Equity Grant)	(1)	06/25/2026		A		15,532		(2)	(2)	Common Stock	15,532	$0	15,532	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. The restricted stock units will vest on June 25, 2027.

Remarks:

	/s/ Euna Greene, attorney-in-fact for Richard Scott Huennekens	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)